 |
 |

Relationship of Type 1 Cannabinoid Receptor Availability in the Human Brain to Novelty-Seeking Temperament
Koen Van Laere, MD, PhD, DrSc;
Karolien Goffin, MD;
Guy Bormans, PhD;
Cindy Casteels, MSc;
Luc Mortelmans, MD, PhD, Ir;
Jan de Hoon, MD, PhD, MSc;
Igor Grachev, MD, PhD;
Mathieu Vandenbulcke, MD, PhD;
Guido Pieters, MD, PhD
Arch Gen Psychiatry. 2009;66(2):196-204.
Context Brain neurochemistry can partially account for personality traits as a variance of normal human behavior, as has been demonstrated for monoamine neurotransmission. Positron emission tomography using fluorine 18–labeled MK-9470 now enables quantification of type 1 cannabinoid receptors (CB1R) in the brain.
Objective To investigate whether there is a relationship between human temperament traits and regional cerebral CB1R availability.
Design Forty-seven [18F]MK-9470 baseline scanning sessions were performed and correlated with the temperament dimensions and subdimensions of the 240-item Cloninger Temperament and Character Inventory.
Setting Academic brain imaging center.
Participants Forty-seven nonsmoking, healthy volunteers (paid).
Main Outcome Measure Voxel-based correlation of temperament variables of the inventory with regional CB1R availability.
Results Novelty seeking was inversely correlated with global CB1R availability (r = –0.33, P = .02), with the most significant correlation in the left amygdala (r = –0.41, P = .005). In particular, the subdimension extravagance showed a highly significant inverse correlation to global CB1R availability (r = –0.53, P <.001), most pronounced in the amygdala, anterior cingulate, parietal cortex, and precuneus. Also, disorderliness was inversely correlated with global CB1R availability (r = –0.31, P = .04).
Conclusions Low baseline cerebral CB1R availability is related to a high novelty-seeking personality, in particular to extravagance, most pronounced in the amygdala. Further investigation of the functional role of the CB1R is warranted in pathological behavior known to be strongly related to novelty seeking, such as addiction and eating disorders.
Author Affiliations: Division of Nuclear Medicine, Katholieke Universiteit Leuven and University Hospital Leuven, Leuven, Belgium (Drs Van Laere, Goffin, and Mortelmans and Ms Casteels); Laboratory for Radiopharmacy (Dr Bormans) and Department of Psychiatry (Drs Vandenbulcke and Pieters), Katholieke Universiteit Leuven; Centre for Clinical Pharmacology, University Hospital Leuven (Dr de Hoon); and Imaging Research Laboratories, Merck Inc, West Point, Pennsylvania (Dr Grachev).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
RELATED ARTICLE
This Month in Archives of General Psychiatry
Arch Gen Psychiatry. 2009;66(2):121.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
To Stop or Not to Stop?
Volkow and Baler
Science 2012;335:546-548.
ABSTRACT
| FULL TEXT
|